Projects per year
Personal profile
Personal profile
Member, Institute for Human Infections & Immunity
Fingerprint Dive into the research topics where David Beasley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 25 Similar Profiles
West Nile virus
Medicine & Life Sciences
Flavivirus
Medicine & Life Sciences
Viruses
Medicine & Life Sciences
Viral Envelope Proteins
Medicine & Life Sciences
Vaccines
Medicine & Life Sciences
Dengue Virus
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2010 2024
Pre-Clinical Models of Infectious Diseases - Part C: Non-Traditional and Animal Replacement Models of Infectious Diseases
7/14/17 → 7/13/24
Project: Other project
Pre-Clinical Models of Infectious Diseases - Part A: Small Animal Models of Infectious Diseases
7/14/17 → 7/13/24
Project: Other project
Pre-Clinical Models of Infectious Diseases - Part B: Non-Human Primate (NHP) Models of Infectious Diseases
7/14/17 → 7/13/24
Project: Other project
Research Output 1997 2018
16
Citations
(Scopus)
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development review-article
Hallam, H. J., Hallam, S., Rodriguez, S. E., Barrett, A., Beasley, D., Chua, A., Ksiazek, T., Milligan, G., Sathiyamoorthy, V. & Reece, L. M., Dec 1 2018, In : npj Vaccines. 3, 1, 11.Research output: Contribution to journal › Article
Lassa Fever
Lassa virus
Virology
Epidemiology
Vaccines
3
Citations
(Scopus)
Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development
Reece, L. M., Beasley, D., Milligan, G., Sarathy, V. & Barrett, A., Apr 1 2018, In : Current Opinion in Virology. 29, p. 72-78 7 p.Research output: Contribution to journal › Review article
Thrombocytopenia
Fever
Vaccines
Viruses
Phlebovirus
1
Citation
(Scopus)
Defining a correlate of protection for chikungunya virus vaccines
Milligan, G., Schnierle, B. S., McAuley, A. J. & Beasley, D., Jan 1 2018, (Accepted/In press) In : Vaccine.Research output: Contribution to journal › Article
Chikungunya virus
Vaccines
Clinical Trials
vaccines
complications (disease)
3
Citations
(Scopus)
Zika virus infection elicits auto-antibodies to C1q
Koma, T., Veljkovic, V., Anderson, D. E., Wang, L. F., Rossi, S., Shan, C., Shi, P-Y., Beasley, D., Bukreyeva, N., Smith, J. N., Hallam, S., Huang, C., Von Messling, V. & Paessler, S., Dec 1 2018, In : Scientific Reports. 8, 1, 1882.Research output: Contribution to journal › Article
Antibodies
Complement C1q
Viral Structures
Microcephaly
Asymptomatic Infections
5
Citations
(Scopus)
Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
McAuley, A. J., Sawatsky, B., Ksiazek, T., Torres, M., Korva, M., Lotrič-Furlan, S., Avšič-Županc, T., Von Messling, V., Holbrook, M. R., Freiberg, A., Beasley, D. & Bente, D., Dec 1 2017, In : npj Vaccines. 2, 1, 9.Research output: Contribution to journal › Article
Tick-Borne Diseases
Tick-Borne Encephalitis Viruses
Tick-Borne Encephalitis
Vaccination
Vaccines